This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schmidt, R. Articles by Hartung, H.-P. Search for Related Content PubMed PubMed Citation Articles by Schmidt, R. Articles by Hartung, H.-P. Related Collections Lipid and lipoprotein metabolism Cerebral Lacunes Genetics of Stroke Computerized tomography and Magnetic Resonance Imaging Risk Factors for Stroke

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:1811.)
© 2000 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

MRI Cerebral White Matter Lesions and Paraoxonase PON1 Polymorphisms

Three-Year Follow-Up of the Austrian Stroke Prevention Study

Reinhold Schmidt; Helena Schmidt; Franz Fazekas; Peter Kapeller; Gudrun Roob; Anita Lechner; Gert M. Kostner; Hans-Peter Hartung

From the Department of Neurology (R.S., F.F., P.K., G.R., A.L., H-P.H.), the Institute of Medical Biochemistry (H.S., G.M.K.), and the MRI Center (R.S., F.F., P.K.), Karl-Franzens University, Graz, Austria.

Correspondence to Dr Reinhold Schmidt, Department of Neurology, Karl-Franzens University, Auenbruggerplatz 23, A-8036 Graz, Austria. E-mail reinhold.schmidt{at}kfunigraz.ac.at

Abstract—White matter lesions (WMLs) on magnetic resonance imaging (MRI) scans of older persons are thought to be caused by cerebral small-vessel disease. As they progress, these brain abnormalities frequently result in cognitive decline and gait disturbances, and their predictors are incompletely understood. Genetic risk factors have been implicated but remain undetermined so far. We examined whether 2 common polymorphisms of the paraoxonase (PON1) gene leading to a methionine (M allele)–leucine (L allele) interchange at position 54 and an arginine (B allele)–glutamine (A allele) interchange at position 191 are associated with the presence and progression of WMLs. We studied 264 community-dwelling subjects without neuropsychiatric disease (ages 44 to 75 years). All underwent vascular risk factor assessment, brain MRI, and PON1 genotyping. MRI scanning was repeated after 3 years. The extent and number of WMLs were recorded by 3 independent readers. Progression of WMLs was assessed by direct scan comparison. The final rating relied on the majority judgment of the 3 readers. The LL, LM, and MM genotypes were noted in 111 (42.0%), 118 (44.7%), and 35 (13.3%) subjects, respectively; the AA, AB, and BB genotypes occurred in 146 (55.3%), 98 (37.1%), and 20 (7.8%) individuals, respectively. Carriers of the LL genotype showed a nonsignificant trend toward more extensive WMLs and more frequently demonstrated lesion progression over the 3-year observation period (P=0.03). The polymorphism at position 191 had no effect. Logistic regression analysis yielded age (odds ratio, 1.08/y), diastolic blood pressure (odds ratio, 1.05/mm Hg), and LL paraoxonase genotype (odds ratio, 2.65) to be significant predictors of WML progression. These data suggest that the LL PON1 genotype at position 54 influences the extent and progression of WMLs in elderly subjects.

Key Words: white matter lesions • cerebral small-vessel disease • paraoxonase • genetics

This article has been cited by other articles:

				H. Ay, E. M. Arsava, J. Rosand, K. L. Furie, A. B. Singhal, P. W. Schaefer, O. Wu, R. G. Gonzalez, W. J. Koroshetz, and A. G. Sorensen Severity of Leukoaraiosis and Susceptibility to Infarct Growth in Acute Stroke Stroke, May 1, 2008; 39(5): 1409 - 1413. [Abstract] [Full Text] [PDF]

				C. S. Carlson, P. J. Heagerty, T. S. Hatsukami, R. J. Richter, J. Ranchalis, J. Lewis, T. J. Bacus, L. A. McKinstry, G. D. Schellenberg, M. Rieder, et al. TagSNP analyses of the PON gene cluster: effects on PON1 activity, LDL oxidative susceptibility, and vascular disease J. Lipid Res., May 1, 2006; 47(5): 1014 - 1024. [Abstract] [Full Text] [PDF]

				H. Shibata, T. Nabika, H. Moriyama, J. Masuda, and S. Kobayashi Correlation of NO Metabolites and 8-Iso-Prostaglandin F2a With Periventricular Hyperintensity Severity Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1659 - 1663. [Abstract] [Full Text] [PDF]

				S. T. Turner, C. R. Jack, M. Fornage, T. H. Mosley, E. Boerwinkle, and M. de Andrade Heritability of Leukoaraiosis in Hypertensive Sibships Hypertension, February 1, 2004; 43(2): 483 - 487. [Abstract] [Full Text] [PDF]

				B. Voetsch, K. S. Benke, B. P. Damasceno, L. H. Siqueira, and J. Loscalzo Paraoxonase 192 Gln->Arg Polymorphism: An Independent Risk Factor for Nonfatal Arterial Ischemic Stroke Among Young Adults Stroke, June 1, 2002; 33(6): 1459 - 1464. [Abstract] [Full Text] [PDF]

				J.R. Marstrand, E. Garde, E. Rostrup, P. Ring, S. Rosenbaum, E.L. Mortensen, and H.B.W. Larsson Cerebral Perfusion and Cerebrovascular Reactivity Are Reduced in White Matter Hyperintensities Stroke, April 1, 2002; 33(4): 972 - 976. [Abstract] [Full Text] [PDF]

				P. N. Durrington, B. Mackness, and M. I. Mackness Paraoxonase and Atherosclerosis Arterioscler. Thromb. Vasc. Biol., April 1, 2001; 21(4): 473 - 480. [Abstract] [Full Text] [PDF]